Table 2.
Author (year) | Drug | Sample size | Study design | Major results |
---|---|---|---|---|
Abraham [1983] | Benzodiazepines Phenothiazines | 21 | Observational study | 8 of the 9 subjects receiving benzodiazepines reported a reduced intensity and frequency of visual disturbances, whereas 11 of 12 subjects receiving phenothiazines reported exacerbation of HPPD |
Abraham and Mamen [1996] | Risperidone | 3 | Case reports | 3 patients with HPPD treated with risperidone reported an exacerbation of LSD-like panic and visual symptoms |
Lerner et al. [1997] | Naltrexone | 2 | Case reports | Dramatic improvement with naltrexone (50 mg daily) was reported in two young men with LSD-induced HPPD. The remission was sustained as it was possible to discontinue the naltrexone after 2 months without precipitating a relapse |
Lerner et al. [2000] | Clonidine | 8 | Observational study | 6 of the 8 subjects (2 dropped out) received clonidine (0.025 mg, three times a day) for 2 months which alleviated LSD-related HPPD |
Lerner et al. [2001] | Clonazepam | 2 | Case reports | 2 outpatients with LSD-induced HPPD were successfully treated with clonazepam. They had not responded to low doses of classic antipsychotics or low-potency benzodiazepines |
Lerner et al. [2002a] | Reboxetine | 1 | Case report | During a 6-month follow-up period on reboxetine (6mg/day) no exacerbations of visual disturbance were reported |
Lerner et al. [2003] | Clonazepam | 16 | Observational study | 16 patients received clonazepam 2 mg/day for 2 months. Patients reported significant relief during clonazepam administration.This improvement persisted during a 6-month follow-up period |
Espiard et al. [2005] | Olanzapine Risperidone Sertraline | 1 | Case report | A case of a young man presenting with HPPD after a mixed intoxication with psilocybin and cannabis. Olanzapine (5 mg) exacerbated symptoms and was replaced by risperidone (2 mg/day) and sertraline (150 mg/day). After 6 months of this treatment HPPD disappeared |
HPPD, hallucinogen-persisting perception disorder; LSD, lysergic acid diethylamide.